Industry News
Draft stem cell laws now out for consultation
National legislation on the use of embryonic stem cells in research is on track to be introduced to Parliament next month. [ + ]
Mimotopes and Baker combine on cardio treatment
A letter of intent to jointly develop a new class of drugs for the treatment of congestive heart failure and other cardiovascular diseases has been signed by combinatorial and medicinal chemistry company Mimotopes and the Baker Medical Research Institute. [ + ]
Cellestis teams up to test TB
Diagnostics developer Cellestis has entered a collaboration to test and distribute a tuberculosis diagnostic designed specifically for the Japanese market. [ + ]
Share price increase follows Biotron's HIV success
Canberra biotech Biotron has announced that its lead anti-HIV compound, BIT009 has shown inhibition of HIV-1 replication in infected human cells. [ + ]
New members for Anadis' advisory panel
One local and one international scientist have joined the ranks of natural biopharmaceutical developer Anadis. [ + ]
$20 million Tasmania bio-informatics centre
A $20 million Centre of Excellence in bio-informatics has been created for Tasmania under the Federal Government's $40 million Intelligent Island program.
[ + ]Portland Orthopaedics expands
Medical device company Portland Orthopaedics has expanded into a larger Sydney-based facility to develop and manufacture its new style of hip and knee replacement joints. [ + ]
Tocovite claims its technology delivers
Melbourne-based company Tocovite claims an absorption system that it has developed could improve drug delivery through the skin. [ + ]
CRC students digging ethical minefields
Last week's Cooperative Research Centre Association conference revealed that ethical issues and public consultation are pertinent to the technological developments currently undertaken by Australian CRCs. [ + ]
Prima's investment to assist cancer research
An investment in a novel monoclonal antibody with anti-cancer properties was announced today by Prima BioMed. [ + ]
IDT buys clinical trials research unit
Contract research group Institute of Drug Technology Australia (ASX: IDT) has purchased a clinical trials research unit in a deal the company said will bolster its annual revenue by 20 per cent. [ + ]
ResMed chases cardiac treatment market
Sleep disorder device company ResMed is on track to market its AutoSet CS device for the treatment of patients of cardiac heart failure. [ + ]
AusBiotech calls for action on R&D Start
Peak biotechnology industry organisation AusBiotech will urge the Federal government to announce the future of the R&D Start scheme on July 1. [ + ]
Science Industry Australia - NSW branch meeting
The next meeting of the NSW Chapter of Science Industry Australia will be held on June 6 at the Silverwater Club.
[ + ]US man first to receive Sirtex cancer treatment
Anti-cancer treatment SIR-Spheres, designed by Sydney-based company Sirtex, has been used on a patient for the first time since it received US Food and Drug Administration (FDA) approval in March this year. [ + ]
